Medline MDLN
NASDAQ MDLN
$32.38 -1.67 (-4.90%)
As of: Sep 10, 2026 · 3:59 PM EDT

Medline (MDLN) EBT Margin (2025 - 2026)

Medline's (MDLN) quarterly EBT Margin came in at 3.06% in Q2 2026, down 216.0% year-over-year from 2.64% in Q2 2025, and down 22.74% quarter-over-quarter from 3.96% in Q1 2026.

Analysis

Medline (MDLN) EBT Margin (2025 - 2026) Analysis & Trends

Medline (MDLN) has reported EBT Margin for 2 consecutive years, with 3.06% the latest figure, recorded in Q2 2026.

  • On a quarterly basis, EBT Margin fell 216.0% year-over-year to 3.06% in Q2 2026; TTM through Jun 2026 was 4.28%, a N/A change from a year earlier, with the FY2025 full-year figure at 4.39%, down 50.0% from the prior year.
  • EBT Margin was 3.06% for Q2 2026 at Medline, down from 3.96% in the prior quarter.
  • Over five years, EBT Margin peaked at 5.21% in Q2 2025 and troughed at 3.06% in Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Becton Dickinson 48.41 Bn 47.55 Bn 2.32 Bn 11.12%
2 Medline 27.78 Bn 25.10 Bn 2.22 Bn 3.06%
3 West Pharmaceutical Services 24.42 Bn 23.98 Bn 329.20 Mn 20.65%
4 Baxter International 12.49 Bn 10.34 Bn 1.03 Bn 5.34%
5 Stevanato Group S.p.A 5.70 Bn 5.59 Bn 100.91 Mn 12.62%
6 Acme United 235.29 Mn 230.25 Mn 26.69 Mn 10.05%
7 Rockwell Medical 31.39 Mn 6.60 Mn 3.24 Mn -7.32%
8 Retractable Technologies 21.15 Mn -18.72 Mn 190,852.00 39.34%
9 United Health Products 8.85 Mn 8.82 Mn - -
10 Cuprina Holdings (Cayman) 7.88 Mn 4.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 3.06%
Mar 28, 2026 3.96%
Jun 28, 2025 5.21%
Mar 29, 2025 5.09%